Wandercraft announced today that it received FDA clearance for its Atalante X exoskeleton for individuals with spinal cord injuries (SCIs). The FDA granted clearance for people with SCIs at levels T5 to L5 to utilize the self-balancing robotic exoskeleton technology. The system enables those with limited mobility to stand up and walk again. Wandercraft says […]
wandercraft
Robotic rehab-focused exoskeleton dev Wandercraft raises $18m Series B
Robotic exoskeleton developer Wandercraft has raised $17.8 million in a Series B funding round, according to a ZDNet report. Funds from the round are slated to support certifications and regulatory clearances necessary to bring the exoskeleton to market, according to the report. The Paris-based company claims that its exoskeleton is the 1st to have managed […]